PRO Act

Bill: 115-hr-5718
Sponsor: full_name: Rep. Smith, Jason [R-MO-8]
Introduced: 2018-05-09
Policy area: Health
Subjects: Advisory bodies

Cardiovascular and respiratory health

Congressional oversight

Drug therapy

Drug trafficking and controlled substances

Drug, alcohol, tobacco use

Government information and archives

Health information and medical records

Home and outpatient care

Hospital care

Medicare

Prescription drugs

Solid waste and recycling

Surgery and anesthesia
Latest action: action_date: 2018-05-23
text: Referred to the Subcommittee on Health.

Summaries:
action_date: 2018-05-09
action_desc: Introduced in House
text: <p><b>Perioperative Reduction of Opioids Act or the PRO Act</b></p> <p>This bill requires the Department of Health and Human Services (HHS) to convene a technical expert panel to recommend ways to reduce opioid use in surgical settings and best practices for pain management, specifically during the perioperative (pre-operative through post-operative) period. </p> <p>HHS must also report on diagnosis-related group codes that have the highest volume of surgeries and the availability of associated data regarding post-operative opioid use, including prescription patterns and rates of consumption. </p>

tv_txt: I 115th CONGRESS 2d Session H. R. 5718 IN THE HOUSE OF REPRESENTATIVES May 9, 2018 Mr. Smith of Missouri (for himself and Mr. Higgins of New York ) introduced the following bill; which was referred to the Committee on Energy and Commerce , and in addition to the Committee on Ways and Means , for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned A BILL To provide for a technical expert panel to provide recommendations on reducing opioid use in the surgical setting and on best practices for pain management, and for other purposes.

1. Short title This Act may be cited as the Perioperative Reduction of Opioids Act or the PRO Act . 2. Technical expert panel on reducing surgical setting opioid use; data collection on perioperative opioid use (a) Technical expert panel on reducing surgical setting opioid use (1) In general Not later than 6 months after the date of the enactment of this Act, the Secretary of Health and Human Services shall convene a technical expert panel, including medical and surgical specialty societies, to provide recommendations on reducing opioid use in the inpatient and outpatient surgical settings and on best practices for pain management, including with respect to the following: (A) Approaches that limit patient exposure to opioids during the perioperative period, including pre-surgical and post-surgical injections. (B) Shared decisionmaking with patients and families on pain management, including recommendations for the development of an evaluation and management code for purposes of payment under the Medicare program under title XVIII of the Social Security Act that would account for time spent on shared decisionmaking. (C) Education on the safe use, storage, and disposal of opioids. (D) Prevention of opioid misuse and abuse after discharge. (E) Development of a clinical algorithm to treat opiate tolerant patients and reduce reliance on opiates for acute pain during the perioperative period. (2) Report Not later than 1 year after the date of the enactment of this Act, the Secretary shall submit to Congress and make public a report containing the recommendations developed under paragraph (1) and recommendations for broader implementation of pain management protocols that limit the use of opioids in the perioperative setting and upon discharge from such setting. (b) Data collection on perioperative opioid use Not later than 1 year after the date of the enactment of this Act, the Secretary of Health and Human Services shall submit to Congress a report that contains the following: (1) The diagnosis-related group codes identified by the Secretary as having the highest volume of surgeries. (2) With respect to each of such diagnosis-related group codes so identified, a determination by the Secretary of the data that is both available and reported on opioid use following such surgeries, such as with respect to— (A) surgical volumes, practices, and opioid prescribing patterns; (B) opioid consumption, including— (i) perioperative days of therapy; (ii) average daily dose at hospital, including high dosage greater than 90 milligram morphine equivalent; (iii) post-discharge prescriptions and other combination drugs that are used before intervention and after intervention; (iv) quantity and duration of opioid prescription at discharge; and (v) quantity consumed and number of refills; (C) regional anesthesia and analgesia practices, including pre-surgical and post-surgical injections; (D) naloxone reversal; (E) post-operative respiratory failure; (F) information about storage and disposal; and (G) such other information as the Secretary may specify. (3) Recommendations for improving data collection on perioperative opioid use, including an analysis to identify barriers to collecting, reporting, and analyzing the data described in paragraph (2), including barriers related to technological availability.